​

Clorox Company (CLX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CLX Stock Forecast

Clorox Company stock forecast is as follows: an average price target of $147.00 (represents a -10.61% downside from CLX’s last price of $164.44) and a rating consensus of 'Buy', based on 21 wall street analysts offering a 1-year stock forecast.

CLX Price Target

The average price target for Clorox Company (CLX) is $147.00 based on 1-year price targets from 21 Wall Street analysts in the past 3 months, with a price target range of $187.00 to $122.00. This represents a potential -10.61% downside from CLX's last price of $164.44.

CLX Analyst Ratings

Buy

According to 21 Wall Street analysts, Clorox Company's rating consensus is 'Buy'. The analyst rating breakdown for CLX stock is 0 'Strong Buy' (0.00%), 9 'Buy' (42.86%), 9 'Hold' (42.86%), 3 'Sell' (14.29%), and 0 'Strong Sell' (0.00%).

Clorox Company Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2024Bonnie HerzogGoldman Sachs$132.00$159.56-17.28%-19.73%
Oct 01, 2024Kaumil GajrawalaJefferies$187.00$165.8312.77%13.72%
Jul 19, 2024Lauren LiebermanBarclays$122.00$136.31-10.50%-25.81%
May 02, 2024Chris CareyWells Fargo$135.00$139.63-3.32%-17.90%
Mar 26, 2024Kaumil GajrawalaJefferies$145.00$150.52-3.67%-11.82%
Jan 30, 2024Nik ModiRBC Capital$138.00$145.97-5.46%-16.08%
Oct 05, 2023Olivia TongRaymond James$185.00$124.6948.37%12.50%
Sep 08, 2023Ken GoldmanJ.P. Morgan$153.00$155.10-1.35%-6.96%
Feb 03, 2023Morgan Stanley$145.00$141.002.84%-11.82%
Feb 03, 2023Raymond James$165.00$141.0017.02%0.34%
Feb 01, 2023Jefferies$145.00$143.321.17%-11.82%
Jan 03, 2023Wells Fargo$135.00$140.39-3.84%-17.90%
Dec 06, 2022Deutsche Bank$151.00$146.702.93%-8.17%
Aug 19, 2022Barclays$101.00$148.71-32.08%-38.58%
Jul 12, 2022Olivia TongRaymond James$160.00$143.8911.20%-2.70%
May 03, 2022D.A. Davidson$123.00$147.56-16.64%-25.20%
May 03, 2022Morgan Stanley$137.00$143.28-4.38%-16.69%
May 03, 2022Wells Fargo$130.00$143.28-9.27%-20.94%
Apr 29, 2022Lauren LiebermanBarclays$117.00$148.34-21.13%-28.85%
Apr 29, 2022Andrea Faria TeixeiraJ.P. Morgan$126.00$148.34-15.06%-23.38%
Apr 24, 2022Steve PowersDeutsche Bank$146.00$150.65-3.09%-11.21%
Feb 08, 2022Linda Bolton WeiserD.A. Davidson$127.00$143.22-11.33%-22.77%
Feb 04, 2022Peter GromUBS$148.00$141.414.66%-10.00%
Feb 02, 2022Callum ElliottBernstein$155.00$166.99-7.18%-5.74%
Jan 26, 2022Kaumil GajrawalaCredit Suisse$160.00$164.72-2.87%-2.70%
Jan 05, 2022Kevin GrundyJefferies$185.00$176.274.95%12.50%

The latest Clorox Company stock forecast, released on Oct 08, 2024 by Bonnie Herzog from Goldman Sachs, set a price target of $132.00, which represents a -17.28% decrease from the stock price at the time of the forecast ($159.56), and a -19.73% decrease from CLX last price ($164.44).

Clorox Company Price Target by Period

1M3M12M
# Anlaysts-26
Avg Price Target-$159.50$143.17
Last Closing Price$164.44$164.44$164.44
Upside/Downside-100.00%-3.00%-12.93%

In the current month, the average price target of Clorox Company stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Clorox Company's last price of $164.44. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Oct 11, 2024BarclaysUnderweightUnderweightHold
Oct 08, 2024Goldman SachsSellSellHold
Oct 01, 2024Wells FargoBuyBuyHold
Oct 01, 2024JefferiesHoldBuyUpgrade
Aug 28, 2024CitigroupNeutralNeutralHold
Jul 22, 2024Cowen & Co.SellBuyInitialise
Jul 22, 2024Cowen & Co.SellInitialise
Jul 19, 2024BarclaysUnderweightUnderweightHold
Jul 10, 2024CitigroupNeutralNeutralHold
Jun 24, 2024Wells FargoHoldHoldHold
Jun 24, 2024Exane BNP ParibasUnderperformInitialise
May 02, 2024Wells FargoUnderweightUnderweightHold
Apr 16, 2024UBSEqual-WeightEqual-WeightHold
Apr 02, 2024CitigroupBuyNeutralDowngrade
Jan 30, 2024RBC CapitalSector PerformSector PerformHold
Dec 15, 2023Bank of America SecuritiesNeutralUpgrade
Nov 22, 2023RBC CapitalNeutralUpgrade
Nov 06, 2023UBSSellNeutralUpgrade
Nov 02, 2023Piper SandlerNeutralNeutralHold
Nov 02, 2023CitigroupBuyUpgrade
Oct 12, 2023BernsteinMarket PerformUpgrade
Oct 02, 2023BTIGNeutralUpgrade
Oct 02, 2023Morgan StanleyEqual-WeightOverweightUpgrade
Oct 02, 2023Wells FargoUnderweightEqual-WeightDowngrade
Oct 02, 2023BarclaysUnderweightEqual-WeightDowngrade
Sep 19, 2023Wells FargoUnderweightUnderweightHold
Sep 08, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Aug 07, 2023Morgan StanleyNeutralNeutralHold
Aug 03, 2023Atlantic EquitiesNeutralUpgrade
Feb 06, 2023BarclaysUnderweightUnderweightHold
Feb 03, 2023Morgan StanleyEqual-WeightEqual-WeightHold
Feb 01, 2023JefferiesHoldHoldHold
Jan 03, 2023Wells FargoUnderweightUnderweightHold
Dec 06, 2022Deutsche BankHoldHoldHold
Nov 02, 2022Credit SuisseUnderperformUnderperformHold
Oct 18, 2022UBSSellSellHold
Oct 18, 2022Evercore PartnersBuyInitialise
Oct 17, 2022Prescience PointBuyPositiveUpgrade
Oct 17, 2022Keefe, Bruyette & WoodsOutperformUpgrade
Oct 17, 2022Prescience PointBuyUpgrade
Sep 13, 2022Wells FargoUnderweightUnderweightHold
Aug 19, 2022BarclaysUnderweightUnderweightHold
Jul 12, 2022Raymond JamesOutperformInitialise
Apr 29, 2022J.P. MorganSellSellHold
Apr 29, 2022BarclaysSellSellHold
Apr 24, 2022Deutsche BankHoldHoldHold
Jan 26, 2022Credit SuisseUnderperformDowngrade
Nov 03, 2020D.A. DavidsonBuyBuyHold

Clorox Company's last stock rating was published by Barclays on Oct 11, 2024. The company gave CLX a "Underweight" rating, the same as its previous rate.

Clorox Company Financial Forecast

Clorox Company Revenue Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Revenue--------------$1.99B$1.39B$2.02B$1.92B$1.72B$1.74B$1.80B$1.81B$1.69B$1.81B$1.80B$1.78B$1.84B$1.92B$1.98B$1.78B
Avg Forecast$2.04B$1.90B$1.77B$1.84B$1.96B$1.82B$1.70B$1.79B$1.90B$1.77B$1.63B$1.65B$1.95B$1.87B$1.80B$1.31B$1.88B$1.82B$1.66B$1.69B$1.86B$1.79B$1.67B$1.70B$1.91B$1.86B$1.75B$1.75B$1.87B$1.71B
High Forecast$2.12B$1.97B$1.84B$1.91B$2.03B$1.89B$1.77B$1.86B$1.97B$1.82B$1.66B$1.65B$1.95B$1.87B$1.82B$1.37B$1.95B$1.89B$1.72B$1.69B$1.86B$1.79B$1.67B$1.70B$1.91B$1.86B$1.75B$1.75B$1.87B$1.71B
Low Forecast$1.99B$1.85B$1.73B$1.80B$1.91B$1.78B$1.66B$1.75B$1.85B$1.73B$1.57B$1.65B$1.95B$1.87B$1.77B$1.27B$1.83B$1.78B$1.62B$1.69B$1.86B$1.79B$1.67B$1.70B$1.91B$1.86B$1.75B$1.75B$1.87B$1.71B
# Analysts476446437994336964374347444999
Surprise %--------------1.10%1.06%1.08%1.05%1.03%1.03%0.97%1.01%1.01%1.06%0.95%0.96%1.05%1.09%1.06%1.04%

Clorox Company's average Quarter revenue forecast for Mar 24 based on 3 analysts is $1.87B, with a low forecast of $1.87B, and a high forecast of $1.87B. CLX's average Quarter revenue forecast represents a -6.04% decrease compared to the company's last Quarter revenue of $1.99B (Dec 23).

Clorox Company EBITDA Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994336964374347444999
EBITDA--------------$390.00M$227.00M$258.00M$224.00M$153.00M$194.00M$166.00M$278.00M$168.00M$264.00M$177.00M$17.00M$407.00M$600.00M$467.00M$366.00M
Avg Forecast$282.63M$262.95M$245.79M$255.48M$271.11M$252.61M$235.77M$247.82M$262.94M$244.85M$225.35M$228.47M$270.13M$216.90M$250.10M$181.16M$260.03M$197.18M$224.40M$250.31M$275.68M$179.26M$246.57M$250.86M$281.79M$15.39M$258.64M$259.40M$277.03M$317.78M
High Forecast$293.61M$273.16M$255.34M$265.40M$281.64M$262.42M$244.93M$257.44M$273.15M$251.76M$229.47M$228.48M$270.13M$260.28M$252.91M$189.93M$270.13M$236.62M$269.28M$250.31M$275.68M$215.11M$246.57M$250.86M$281.79M$18.47M$258.64M$259.40M$277.03M$381.34M
Low Forecast$276.03M$256.81M$240.05M$249.51M$264.78M$246.71M$230.27M$242.03M$256.80M$239.31M$217.10M$228.45M$270.13M$173.52M$245.89M$176.00M$253.96M$157.75M$179.52M$250.31M$275.68M$143.41M$246.57M$250.86M$281.79M$12.31M$258.64M$259.40M$277.03M$254.23M
Surprise %--------------1.56%1.25%0.99%1.14%0.68%0.78%0.60%1.55%0.68%1.05%0.63%1.10%1.57%2.31%1.69%1.15%

3 analysts predict CLX's average Quarter EBITDA for Mar 24 to be $216.90M, with a high of $260.28M and a low of $173.52M. This is -44.38% lower than Clorox Company's previous annual EBITDA (Dec 23) of $390.00M.

Clorox Company Net Income Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994336964374347444999
Net Income--------------$93.00M$22.00M$176.00M$-209.00M$99.00M$85.00M$101.00M$150.00M$72.00M$142.00M$97.00M$-61.00M$259.00M$415.00M$310.00M$241.00M
Avg Forecast$278.61M$228.03M$201.27M$231.67M$256.64M$219.59M$192.72M$234.27M$242.37M$203.32M$173.74M$176.14M$193.80M$117.88M$136.23M$-30.25M$145.57M$107.16M$92.16M$92.96M$115.97M$97.42M$99.41M$129.02M$164.52M$-55.23M$223.02M$289.73M$249.34M$209.25M
High Forecast$292.67M$239.54M$211.43M$243.36M$269.60M$230.67M$202.44M$246.10M$254.60M$208.17M$196.24M$185.21M$193.84M$141.46M$155.15M$-4.12M$147.11M$128.60M$110.60M$92.96M$115.97M$116.91M$99.41M$129.02M$164.52M$-44.18M$223.02M$289.73M$249.34M$251.10M
Low Forecast$270.15M$221.11M$195.16M$224.63M$248.85M$212.92M$186.86M$227.16M$235.01M$197.27M$154.99M$167.08M$193.76M$94.31M$122.36M$-55.00M$144.02M$85.73M$73.73M$92.96M$115.97M$77.94M$99.41M$129.02M$164.52M$-66.28M$223.02M$289.73M$249.34M$167.40M
Surprise %--------------0.68%-0.73%1.21%-1.95%1.07%0.91%0.87%1.54%0.72%1.10%0.59%1.10%1.16%1.43%1.24%1.15%

Clorox Company's average Quarter net income forecast for Mar 24 is $117.88M, with a range of $94.31M to $141.46M. CLX's average Quarter net income forecast represents a 26.75% increase compared to the company's last Quarter net income of $93.00M (Dec 23).

Clorox Company SG&A Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994336964374347444999
SG&A--------------$508.00M$276.00M$540.00M$517.00M$438.00M$422.00M$451.00M$386.00M$408.00M$418.00M$484.00M$437.00M$456.00M$417.00M$493.00M$453.00M
Avg Forecast$515.54M$479.65M$448.35M$466.01M$494.53M$460.79M$430.07M$452.05M$479.63M$446.62M$411.05M$416.74M$492.74M$303.35M$456.20M$330.45M$474.32M$275.77M$544.97M$427.37M$470.69M$250.70M$420.98M$428.31M$481.11M$395.66M$441.59M$442.88M$472.98M$393.32M
High Forecast$535.56M$498.27M$465.76M$484.11M$513.73M$478.68M$446.77M$469.60M$498.25M$459.24M$418.57M$416.77M$492.74M$364.02M$461.33M$346.45M$492.74M$330.93M$653.97M$427.37M$470.69M$300.84M$420.98M$428.31M$481.11M$474.79M$441.59M$442.88M$472.98M$471.99M
Low Forecast$503.50M$468.45M$437.88M$455.13M$482.98M$450.02M$420.03M$441.49M$468.43M$436.53M$396.01M$416.71M$492.74M$242.68M$448.52M$321.05M$463.24M$220.62M$435.98M$427.37M$470.69M$200.56M$420.98M$428.31M$481.11M$316.53M$441.59M$442.88M$472.98M$314.66M
Surprise %--------------1.11%0.84%1.14%1.87%0.80%0.99%0.96%1.54%0.97%0.98%1.01%1.10%1.03%0.94%1.04%1.15%

Clorox Company's average Quarter SG&A projection for Mar 24 is $303.35M, based on 3 Wall Street analysts, with a range of $242.68M to $364.02M. The forecast indicates a -40.29% fall compared to CLX last annual SG&A of $508.00M (Dec 23).

Clorox Company EPS Forecast

Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
# Analysts476446437994336964374347444999
EPS--------------$0.75$0.18$1.43$-1.69$0.81$0.69$0.81$1.22$0.59$1.15$0.79$-0.49$2.06$3.28$2.45$1.92
Avg Forecast$2.23$1.83$1.61$1.86$2.06$1.76$1.55$1.88$1.94$1.63$1.39$1.41$1.55$1.36$1.09$-0.24$1.17$1.23$0.66$0.74$0.93$0.92$0.79$1.03$1.32$1.48$1.78$2.32$1.99$1.67
High Forecast$2.35$1.92$1.70$1.95$2.16$1.85$1.62$1.97$2.04$1.67$1.57$1.49$1.55$1.36$1.24$-0.03$1.18$1.29$0.69$0.74$0.93$0.92$0.79$1.03$1.32$1.48$1.78$2.32$1.99$1.67
Low Forecast$2.17$1.77$1.57$1.80$2.00$1.71$1.50$1.82$1.88$1.58$1.24$1.34$1.55$1.36$0.98$-0.44$1.16$1.19$0.64$0.74$0.93$0.92$0.79$1.03$1.32$1.48$1.78$2.32$1.99$1.67
Surprise %--------------0.69%-0.74%1.22%-1.38%1.23%0.93%0.87%1.32%0.74%1.11%0.60%-0.33%1.16%1.42%1.23%1.15%

According to 3 Wall Street analysts, Clorox Company's projected average Quarter EPS for Mar 24 is $1.36, with a low estimate of $1.36 and a high estimate of $1.36. This represents a 81.53% increase compared to CLX previous annual EPS of $0.75 (Dec 23).

Clorox Company Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ELEstée Lauder Companies$78.18$112.8344.32%Hold
ULUnilever$59.30$71.0019.73%Buy
KMBKimberly-Clark$131.14$155.6718.71%Hold
CLColgate-Palmolive Company$93.49$108.6716.24%Buy
PGProcter & Gamble Company$170.33$173.922.11%Buy
CHDChurch & Dwight$105.80$106.200.38%Hold
CLXClorox Company$163.32$147.00-9.99%Buy

CLX Forecast FAQ

Is Clorox Company a good buy?

Yes, according to 21 Wall Street analysts, Clorox Company (CLX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 9 'Buy' recommendations, accounting for 42.86% of CLX's total ratings.

What is CLX's price target?

Clorox Company (CLX) average price target is $147 with a range of $122 to $187, implying a -10.61% from its last price of $164.44. The data is based on 21 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Clorox Company stock go up soon?

According to Wall Street analysts' prediction for CLX stock, the company can go down by -10.61% (from the last price of $164.44 to the average price target of $147), up by 13.72% based on the highest stock price target, and down by -25.81% based on the lowest stock price target.

Can Clorox Company stock reach $200?

CLX's average twelve months analyst stock price target of $147 does not support the claim that Clorox Company can reach $200 in the near future.

What are Clorox Company's analysts' financial forecasts?

Clorox Company's analysts financial forecasts for the fiscal year (Jun 2026) are as follows: average revenue is $7.27B (high $7.55B, low $7.1B), average EBITDA is $1.01B (high $1.05B, low $983.79M), average net income is $903.22M (high $948.81M, low $875.79M), average SG&A $1.84B (high $1.91B, low $1.79B), and average EPS is $7.24 (high $7.61, low $7.02). CLX's analysts financial forecasts for the fiscal year (Jun 2027) are as follows: average revenue is $7.55B (high $7.85B, low $7.38B), average EBITDA is $1.05B (high $1.09B, low $1.02B), average net income is $939.58M (high $987.01M, low $911.04M), average SG&A $1.91B (high $1.98B, low $1.86B), and average EPS is $7.54 (high $7.92, low $7.31).

Did the CLX's actual financial results beat the analysts' financial forecasts?

Based on Clorox Company's last annual report (Jun 2023), the company's revenue was $7.39B, beating the average analysts forecast of $7.05B by 4.86%. Apple's EBITDA was $773M, missing the average prediction of $931.93M by -17.05%. The company's net income was $149M, missing the average estimation of $437.85M by -65.97%. Apple's SG&A was $1.92B, beating the average forecast of $1.72B by 11.30%. Lastly, the company's EPS was $1.21, missing the average prediction of $3.8 by -68.13%. In terms of the last quarterly report (Dec 2023), Clorox Company's revenue was $1.99B, beating the average analysts' forecast of $1.8B by 10.30%. The company's EBITDA was $390M, beating the average prediction of $250.1M by 55.94%. Clorox Company's net income was $93M, missing the average estimation of $136.23M by -31.73%. The company's SG&A was $508M, beating the average forecast of $456.2M by 11.35%. Lastly, the company's EPS was $0.75, missing the average prediction of $1.09 by -31.36%